242 results on '"Fowler Jr., Vance G."'
Search Results
2. Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study
Catalog
Books, media, physical & digital resources
3. Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data
4. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
5. Author Correction: Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data
6. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
7. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection
8. Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study
9. Intertwining clonality and resistance: Staphylococcus aureus in the antibiotic era.
10. Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria
11. In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals
12. Serum susceptibility of Escherichia coli and its association with patient clinical outcomes.
13. Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia.
14. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
15. Fibrinogen binding is affected by amino acid substitutions in C-terminal repeat region of fibronectin binding protein A
16. In-patient evolution of a high-persister Escherichia coli strain with reduced in vivo antibiotic susceptibility.
17. Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection.
18. Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens.
19. Incidence of and Preoperative Risk Factors for Staphylococcus aureus Bacteremia and Chest Wound Infection After Cardiac Surgery
20. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
21. Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment.
22. Infective endocarditis
23. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?
24. Medical treatment of endocarditis
25. Issues in the management of endocarditis caused by resistant gram-positive organisms
26. The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints
27. Echocardiography for the diagnosis of Staphylococcus aureus infective endocarditis
28. Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.
29. First reported case of infective endocarditis caused by community-acquired methicillin-resistant staphylococcus aureus not associated with healthcare contact in Brazil
30. Ceftobiprole Versus Daptomycin in Staphylococcus Aureus Bacteremia: A Novel Protocol for a Double-Blind, Phase III trial
31. Confronting antimicrobial resistance together.
32. 841. Implications of C. difficile Treatment on Environmental Contamination: A Randomized Controlled Trial with Microbiologic, Environmental, and Molecular Outcomes
33. Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia.
34. Temporal encoding of bacterial identity and traits in growth dynamics.
35. 1039. Surveillance Blood Cultures Associated With Decreased Mortality in Gram-Negative Bacteremia
36. 1058. Prognostic Biomarkers for Persistent Bacteremia and Mortality in Complicated S. aureus Bloodstream Infection
37. Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.
38. Increased risk of Staphylococcus aureus bacteremia in hemodialysis--A nationwide study.
39. Female Sex and Mortality in Patients with Staphylococcus aureus Bacteremia: A Systematic Review and Meta-analysis.
40. Infection of Orthopedic Prostheses after Staphylococcus aureus Bacteremia
41. Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory.
42. Ceftobiprole versus daptomycin in Staphylococcus aureusbacteremia: a novel protocol for a double-blind, Phase III trial
43. Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune Globulin.
44. A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.
45. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
46. The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
47. Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
48. A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
49. Pulse Field Gel Electrophoresis.
50. Identifying and Aligning Expectations in a Mentoring Relationship
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.